Hyderabad: In a significant step towards Hyderabad becoming a hub for drug development, clinical research and drug testing in the country, the Indian Council of Medical Research (ICMR) has decided to set up its prestigious Rs 7 crore National Centre for Product Development at Nizam’s Institute of Medical Sciences (NIMS).
The ICMR centre at NIMS will be the first-of-its-kind in South India and one among five other similar facilities being planned to be set up in Mumbai, Chandigarh, Lucknow and Hyderabad.
As part of the initiative, the council will be setting up a state-of-the-art ‘Pharmacodynamics and Pharmacokinetics’ laboratory-cum-research centre on the seventh floor of NIMS Millennium Block, NIMS Director, Dr K Manohar, said. To draw out an action plan and hammer out other details related to the new clinical research facility, the National Chair of Clinical Pharmacology, ICMR, Dr Nilima Kshirsagar along with two other external experts including Dr Arun Bhatt and Dr Shanti, visited NIMS Hospital to interact with the authorities on Saturday.
“NIMS is the only facility that will have such an ICMR facility in South India. The ICMR National Centre will play an important role in coming up with national guidelines on usage of new and existing drugs, research and development and testing the feasibility of drugs before they are marketed,” said Head, Clinical Pharmacology and Therapeutics, NIMS, Dr P Usha Rani.
Senior officials said the ICMR team was keen to start the project from the present financial year itself. They said the ICMR facility will be a major boost for the development of clinical pharmacology and other allied disciplines including translational and pharmaceutical medicines for the benefit of patients. The ICMR centre is also expected to play a vital role in updating regulatory requirements for new types of drugs including those coming up in AYUSH.